Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-003251-74Phase 3Completed
Phase 3 trial of testosterone and dutasteride in gender dysphoria (GD), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Muscle metabolism and muscle strength. Started Jul 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-003251-74.